Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Utilizing State Cancer Registries to Inform State-Based Cancer Control Efforts for Children.
Journal: Pediatric blood & cancer
Published: April 16, 2025
Feasibility and Clinical Utility of Patient-Reported Outcome Measurement Information System-29 in a Newly Established Adolescent and Young Adult Oncology Program.
Journal: Journal of adolescent and young adult oncology
Published: July 03, 2024
Adolescents and young adults with cancer: the clinical course of COVID-19 infections.
Journal: Journal of the National Cancer Institute
Published: September 26, 2023
Utilization of Teleconsent for Adolescent and Young Adult Cancer Clinical Trials, a Report from the Children's Oncology Group.
Journal: Journal of adolescent and young adult oncology
Published: August 04, 2023
Emergency department utilization and disposition outcomes by pediatric patients with cancer in Maryland and New York from 2013 to 2017.
Journal: Pediatric blood & cancer
Published: January 07, 2023
Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network.
Journal: JCO oncology practice
Published: December 14, 2021
The Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network: A New Model for Addressing Site-Level Factors Impacting Clinical Trial Enrollment.
Journal: Journal of adolescent and young adult oncology
Published: February 21, 2020
Bilateral parotid gland enlargement and palpable nephromegaly in infant acute lymphoblastic leukemia: case report and review of the literature.
Journal: Journal of pediatric hematology/oncology
Published: December 07, 2013
Late effects in survivors of childhood CNS tumors treated on Head Start I and II protocols.
Journal: Pediatric blood & cancer
Published: September 30, 2013
Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity.
Journal: Cytotherapy
Published: June 24, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026